Late Start On Ebola Therapies Means Outbreak Outpacing Drug, Vaccine Development

ScienceInsider: Ebola vaccine: Little and late
“…Administration officials have begun working with industry to speed manufacturing of experimental drugs and vaccines [for Ebola]. ‘We’re trying to do everything we can to scale up product,’ says Nicole Lurie, assistant secretary for preparedness and response at the U.S. Department of Health and Human Services (HHS). But the logistical obstacles are huge, and makers are getting a late start…” (Cohen, 9/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.